Gossamer Bio (GOSS) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -3.37 | 0.14 | 0.52 | -2.83 | -358.0 | -0.84 | ||
| Changes by years, y/y, % | +129% | -104% | +266% | -645% | +12 563% | +200.0% | |||
Gossamer Bio. EV/EBITDA
Gossamer Bio. EV/EBITDA, changes, %
Gossamer Bio (GOSS) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -2.10 | -328.8 | -354.6 | -37.1 | -15.0 | -0.84 | |
| Changes by years, y/y, % | -180% | +17 101% | +12 402% | +581% | +614% | |||
| Changes by quarters, q/q, % | -62% | +15 591% | +8% | -90% | -60% | |||